RESUMO
A variety of acute oral lesions may be encountered in the scope of dermatology. Oral lesions may be single or multiple; may arise secondary to infectious, immune, congenital, medication use, or idiopathic causes; and may take a variety of forms. A thorough evaluation of the oral cavity is required to assess patients with oral lesions. Affected patients may be monitored, treated, or referred to an appropriate specialist for further management as needed. Many acute oral lesions are self-limiting in nature and patients may require only assessment and reassurance. Several common acute oral lesions are discussed in this article.
Assuntos
Doenças da Boca/imunologia , Doenças da Boca/microbiologia , Doença Aguda , Infecções por Coxsackievirus/complicações , Eritema Multiforme/complicações , Eritema Multiforme/diagnóstico , Herpes Simples/complicações , Humanos , Doenças Inflamatórias Intestinais/complicações , Úlceras Orais/etiologia , Estomatite Aftosa/complicações , Estomatite Aftosa/terapia , Estomatite Herpética/complicações , Infecção pelo Vírus da Varicela-Zoster/complicações , Ferimentos e Lesões/complicaçõesRESUMO
INTRODUCTION: Chronic mucocutaneous candidiasis (CMC) is characterized by susceptibility to chronic or recurrent infections with yeasts of the genus Candida affecting the skin, nails and mucous membranes. We describe a Moroccan patient presenting CMC with heterozygous STAT1 gain-of-function (GOF) mutation. PATIENTS AND METHODS: A 5-year-old boy with no consanguinity presented recurrent episodes of oral thrush, chronic nail candidiasis and herpetic gingivostomatitis from the age of 8 months. He also had mycobacterial adenitis secondary to BCG vaccination and atypical rosacea. Genetic analysis revealed GOF mutation of the STAT1 gene. DISCUSSION: CMC was diagnosed in our patient despite poor clinical features. Sequencing of the genome revealed STAT1GOF mutation. This mutation affects production of IL-17, an important cytokine in mucocutaneous defense against Candida. The association with mycobacterial adenitis is rare and continues to be poorly understood. The presence of atypical rosacea in this setting is suggestive of this entity. Antifungal therapy and prevention of complications are necessary to reduce the morbidity and mortality associated with this condition. CONCLUSION: CMC due to STAT1GOF mutation is characterized by a broad clinical spectrum and should be considered in all cases of chronic or recurrent fungal infection, whether or not associated with other infections.
Assuntos
Candidíase Mucocutânea Crônica/genética , Mutação com Ganho de Função , Fator de Transcrição STAT1/genética , Adjuvantes Imunológicos/efeitos adversos , Vacina BCG/efeitos adversos , Candidíase Mucocutânea Crônica/complicações , Candidíase Bucal/complicações , Calázio/complicações , Pré-Escolar , Doença Crônica , Doenças da Gengiva/virologia , Humanos , Linfadenite/microbiologia , Masculino , Infecções por Mycobacterium/complicações , Onicomicose/complicações , Estomatite Herpética/complicaçõesAssuntos
Anestesia Dentária/veterinária , Doenças do Gato/cirurgia , Intubação Intratraqueal/veterinária , Estomatite Herpética/veterinária , Tonsilite/veterinária , Animais , Gatos , Falha de Equipamento/veterinária , Intubação Intratraqueal/instrumentação , Letargia/etiologia , Letargia/veterinária , Masculino , Estomatite Herpética/complicações , Estomatite Herpética/diagnóstico , Estomatite Herpética/cirurgia , Tonsilite/complicações , Tonsilite/diagnóstico , Tonsilite/cirurgiaRESUMO
Research objective was to study the effectiveness of complex treatment of recurrent herpetic stomatitis with dysbiosis. The study included 147 patients aged from 18 to 45 years with recurrent herpetic stomatitis (RGS) and disbyosis divided in 3 groups. Group 1 received conventional antiviral and symptomatic treatment of RGS, in group 2 complex immunoglobulins (IgA (15-25%), IgM (15-25%) and Ig (50-70%)) were added to conventional therapy, group 3 received immunoglobulins only. Clinical and immunological efficiency was estimated by values of oral local immunity (SlgA, lysozyme), humoral immunity (IgE and IgG) and cellular immunity (RBTL with FGA, defined T-lymphocytes). Significant (p<0.05) increase of lisozyme and SlgA, RBTL with FGA, number of T-lymphocytes and IgG concentration was observed in group 2. The obtained data allow improving quality of treatment of recurrent herpetic stomatitis with related dysbiosis.
Assuntos
Disbiose/complicações , Estomatite Herpética/complicações , Estomatite Herpética/tratamento farmacológico , Adolescente , Adulto , Antivirais/uso terapêutico , Quimioterapia Combinada , Feminino , Humanos , Imunidade Celular , Imunoglobulina A/uso terapêutico , Imunoglobulina M/uso terapêutico , Contagem de Linfócitos , Masculino , Pessoa de Meia-Idade , Muramidase/análise , Recidiva , Saliva/enzimologia , Estomatite Herpética/imunologia , Linfócitos T/imunologia , Resultado do Tratamento , Adulto JovemRESUMO
Herpes labialis remains a common worldwide affliction. Recent advances in understanding the basic pathogenesis have led to new therapeutic intervention, both on-label and off-label. Aside from reducing the duration and symptomatology of acute outbreaks, another goal of treatment is to decrease the frequency of future episodes. Oral and topical acyclovir and its analogues are the mainstay of both chronic suppressive and episodic therapy. A new muco-adhesive formulation of acyclovir provides a decrease in outbreaks, probably due to a diminution of herpesvirus load in all reservoir sites. Acyclovir-resistant strains are rare in immunocompetent hosts; parenteral foscarnet and cidofovir are administered in this situation. Parenteral acyclovir is the drug of choice for eczema herpeticum, which may begin as herpes labialis in an atopic dermatitis patient. Thermotherapy may be beneficial, and a certified device to deliver heat is available outside the United States.
J Drugs Dermatol. 2017;16(3 Suppl):s49-53.
.Assuntos
Antivirais/administração & dosagem , Antivirais/uso terapêutico , Herpes Labial/terapia , Herpesvirus Humano 1/efeitos dos fármacos , Estomatite Herpética/terapia , Carga Viral/efeitos dos fármacos , Aciclovir/administração & dosagem , Aciclovir/uso terapêutico , Administração Oral , Administração Tópica , Adulto , Doença Crônica/terapia , Cidofovir , Citosina/administração & dosagem , Citosina/análogos & derivados , Citosina/uso terapêutico , Farmacorresistência Viral , Foscarnet/administração & dosagem , Foscarnet/uso terapêutico , Herpes Labial/complicações , Herpesvirus Humano 1/isolamento & purificação , Herpesvirus Humano 1/fisiologia , Humanos , Hipertermia Induzida , Infusões Parenterais , Organofosfonatos/administração & dosagem , Organofosfonatos/uso terapêutico , Recidiva , Estomatite Herpética/complicaçõesRESUMO
OBJECTIVE: The aim of the study was to explore physician perceptions of the amount of fluid that demonstrates a successful "trial of fluids" (adequate fluid intake) in the emergency department in children who have had insufficient fluid intake at home. METHODS: This is a secondary analysis of a randomized placebo-controlled trial of viscous lidocaine versus placebo in children aged 6 months to 8 years with acute infectious ulcerative mouth conditions (gingivostomatitis, ulcerative pharyngitis, or hand foot and mouth disease) and poor oral fluid intake. We measured the amount of fluid ingested in 60 minutes after administration of the intervention and related physician perception of adequate intake to measured intake. Given that there was little difference in oral intake between the treatment groups, the 2 arms were pooled for this analysis. RESULTS: One hundred participants were recruited (50 per treatment group), all of whom completed the 60-minute trial period. At baseline, 72% were mildly dehydrated, 21% were not dehydrated, and 5% were moderately dehydrated. The participants drank a median of 8.6 mL/kg (interquartile range [IQR], 3.7-14). Clinicians perceived 58% of the participants to have an adequate intake within the first hour after intervention. The median consumption of those whose oral intake was deemed as adequate was 12.6 mL/kg (IQR, 9.4-18.4); for those whose oral intake was not deemed adequate, the median consumption was 2.7 mL/kg (IQR, 0.7-5.3) (rank sum, P < 0.001). CONCLUSIONS: In children undergoing trial of fluids, we found that most clinicians perceived a fluid intake greater than 9 mL/kg as adequate and lower than 5 mL/kg as inadequate.
Assuntos
Desidratação/terapia , Doença de Mão, Pé e Boca/tratamento farmacológico , Lidocaína/administração & dosagem , Faringite/tratamento farmacológico , Médicos/psicologia , Estomatite Herpética/tratamento farmacológico , Criança , Pré-Escolar , Feminino , Hidratação , Doença de Mão, Pé e Boca/complicações , Humanos , Lactente , Masculino , Percepção , Faringite/complicações , Faringite/virologia , Estomatite Herpética/complicações , Resultado do TratamentoAssuntos
Edema da Córnea/diagnóstico , Substância Própria/patologia , Endotélio Corneano/patologia , Ceratite/diagnóstico , Antibacterianos/uso terapêutico , Edema da Córnea/tratamento farmacológico , Substância Própria/efeitos dos fármacos , Topografia da Córnea , Quimioterapia Combinada , Endotélio Corneano/efeitos dos fármacos , Feminino , Fluoroquinolonas/uso terapêutico , Gatifloxacina , Glucocorticoides/uso terapêutico , Humanos , Ceratite/tratamento farmacológico , Microscopia Confocal , Pessoa de Meia-Idade , Soluções Oftálmicas , Prednisolona/análogos & derivados , Prednisolona/uso terapêutico , Estomatite Herpética/complicações , Acuidade VisualRESUMO
Existen muchas situaciones clínicas en las que la identificación de un factor de riesgo inmunológico, cuando es detectado a tiempo y se corrige, puede suponer salvar la vida del paciente. Presentamos datos clínicos e inmunológicos de una paciente con trasplante cardiaco que desarrolla una enfermedad sistémica por citomegalovirus y que no responde a terapia antiviral convencional (AU)
No disponible
Assuntos
Humanos , Feminino , Pessoa de Meia-Idade , Transplante de Coração , Imunologia de Transplantes , Terapia de Imunossupressão/métodos , Agamaglobulinemia/diagnóstico , Fatores de Risco , Diagnóstico Diferencial , Estomatite Herpética/complicaçõesAssuntos
Proteínas ADAM/deficiência , Mutação de Sentido Incorreto , Mutação Puntual , Púrpura Trombocitopênica Trombótica/etiologia , Estomatite Herpética/complicações , Proteínas ADAM/genética , Proteína ADAMTS13 , Adolescente , Adulto , Idade de Início , Erros de Diagnóstico , Feminino , Genótipo , Humanos , Japão/epidemiologia , Masculino , Pessoa de Meia-Idade , Linhagem , Polimorfismo de Nucleotídeo Único , Gravidez , Púrpura Trombocitopênica Idiopática/diagnóstico , Púrpura Trombocitopênica Trombótica/congênito , Púrpura Trombocitopênica Trombótica/diagnóstico , Púrpura Trombocitopênica Trombótica/epidemiologia , Púrpura Trombocitopênica Trombótica/genética , Estados Unidos/epidemiologia , Adulto JovemRESUMO
BACKGROUND: Acute paronychia usually is treated as a bacterial infection, but antibiotic-resistant acute paronychia may be caused by other infectious and noninfectious problems. OBJECTIVE: We sought to describe the clinical, etiologic, cytologic, and therapeutic features of antibiotic-resistant acute paronychia. METHODS: A retrospective review of medical records and cytology was performed in 58 patients (age, 1 month-91 years; 36 children and adolescents [62%] and 22 adults [38%]) who had antibiotic-resistant acute paronychias. RESULTS: Causes of paronychia included bacteria (25 patients [43%]), viruses (21 patients [36%]), fungi (5 patients [9%]), drugs (3 patients [5%]), pemphigus vulgaris (3 patients [5%]), and trauma (1 patient [2%]). Diagnostic cytologic findings were noted in 54 patients (93%); no diagnostic cytologic findings were present with drug-induced (3 patients) or traumatic (1 patient) paronychia. The most common predisposing factors were the habits of finger- or thumb-sucking (14 patients [24%]) and nail-biting (11 patients [19%]). Complications included id reaction with erythema multiforme in 3 patients (5%). LIMITATIONS: Limitations include retrospective study design from 1 treatment center. CONCLUSION: Antibiotic-resistant acute paronychia may be infectious or noninfectious. Cytologic examination with Tzanck smear may be useful diagnostically and may prevent unnecessary use of antibiotics and surgical drainage.
Assuntos
Candidíase Cutânea/complicações , Resistência Microbiana a Medicamentos , Herpes Labial/complicações , Paroniquia/tratamento farmacológico , Paroniquia/etiologia , Infecções Cutâneas Estafilocócicas/complicações , Estomatite Herpética/complicações , Doença Aguda , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Antibacterianos/uso terapêutico , Antifúngicos/uso terapêutico , Antivirais/uso terapêutico , Candidíase Cutânea/diagnóstico , Candidíase Cutânea/tratamento farmacológico , Criança , Pré-Escolar , Sucção de Dedo/efeitos adversos , Herpes Labial/diagnóstico , Herpes Labial/tratamento farmacológico , Humanos , Lactente , Pessoa de Meia-Idade , Hábito de Roer Unhas/efeitos adversos , Paroniquia/patologia , Pênfigo/complicações , Estudos Retrospectivos , Infecções Cutâneas Estafilocócicas/diagnóstico , Infecções Cutâneas Estafilocócicas/tratamento farmacológico , Estomatite Herpética/diagnóstico , Estomatite Herpética/tratamento farmacológico , Ferimentos e Lesões/complicações , Adulto JovemRESUMO
Herpes simplex virus (HSV) is a double-stranded virus belonging to human herpes virus family. Although it exists in eight various forms, HSV-1 causes most of the oral infections. Since dentists are more likely to be consulted in the case of oral infections, familiarity with these lesions becomes mandatory. It is more commonly reported in children and rarely in adults. This article presents an acute episode of primary herpetic gingivostomatitis in a 32-year-old male patient.
Assuntos
Gengivite/virologia , Herpes Simples , Doença Aguda , Adulto , Herpes Simples/complicações , Humanos , Masculino , Estomatite Herpética/complicaçõesRESUMO
La laringitis aguda en niños es una patología frecuente, autolimitada, de breve duración: 2 a 7 días, causada por virus como influenza A y B, parainfluenza 1, 2 y 3, virus respiratorio sincitial (VRS) y adenovirus.Las infecciones prolongadas pueden involucrar otros patógenos; han sido reportados algunos casos de laringitis causadas por infecciones herpéticas, sobre todo por el virus herpes simple tipo 1 (VHS-1).Se sugiere la evaluación endoscópica de la vía aérea en casos de laringitis prolongadas para el diagnóstico e implementar medidas terapéuticas específicas para evitar complicaciones potencialmente graves. El uso de aciclovir ha demostrado ser efectivo en el tratamiento, siendo controvertido el uso de corticoides y antibióticos.Se presenta el caso de una niña de 7 meses con laringitis por Herpes virus, tratado con aciclovir...
Assuntos
Humanos , Feminino , Lactente , Aciclovir/uso terapêutico , Estomatite Herpética/complicações , Estomatite Herpética/diagnóstico , Estomatite Herpética/terapia , Laringite/diagnóstico , Laringite/etiologia , Herpesvirus Humano 1Assuntos
Humanos , Feminino , Adolescente , Esofagite/complicações , Esofagite/diagnóstico , Doença de Darier/complicações , Doença de Darier/diagnóstico , Diagnóstico Diferencial , Aciclovir/uso terapêutico , Esofagite/microbiologia , Esofagite/fisiopatologia , Esofagite , Estomatite Herpética/complicações , Doença de Darier/microbiologia , Transtornos de Deglutição/complicaçõesRESUMO
A previously healthy boy aged 9 years and 11 months was admitted due to herpetic gingivostomatitis with poor intake. He also had fever, neutropenia, and elevated serum aminotransferase level (> 1000 IU/mL). Prolonged prothrombin time, mild gastrointestinal hemorrhage and transient decreased conscious level were noted during hospital days 2 and 3. Intravenous acyclovir therapy commenced on hospital day 2 and his serum aminotransferase level peaked (> 4000 IU/mL) on hospital day 3 and then improved gradually. A throat swab was positive for human herpes simplex virus (HSV)-1, serological test was positive for acute primary HSV-1 infection, and a blood specimen was also strongly positive for HSV-1 by polymerase chain reaction. He received a 14-day course of intravenous acyclovir and recovered uneventfully. Herpetic gingivostomatitis, although mostly benign and self-limited, may be complicated with severe hepatitis, even in immunocompetent hosts.
Assuntos
Hepatite/complicações , Herpesvirus Humano 1/isolamento & purificação , Estomatite Herpética/complicações , Aciclovir/uso terapêutico , Administração Intravenosa , Antivirais/uso terapêutico , Criança , Febre/complicações , Febre/tratamento farmacológico , Febre/fisiopatologia , Hepatite/tratamento farmacológico , Hepatite/fisiopatologia , Herpesvirus Humano 1/patogenicidade , Humanos , Masculino , Neutropenia/complicações , Neutropenia/tratamento farmacológico , Neutropenia/fisiopatologia , Testes Sorológicos , Manejo de Espécimes , Estomatite Herpética/tratamento farmacológico , Estomatite Herpética/fisiopatologia , Transaminases/sangue , Resultado do TratamentoRESUMO
A previously healthy boy was admitted with fever, tachycardia, dyspnea, and was vomiting. A blood test showed a severe metabolic acidosis with pH 7.08 and an anion gap of 36 mmol/L. His urine had an odor of acetone. The serum glucose was 5.6 mmol/L, and no glucosuria was found. Diabetic ketoacidosis could therefore be eliminated. Lactate level was normal. Tests for the most common metabolic diseases were negative. Because of herpes stomatitis, the boy had lost appetite and only been drinking Diet Coke and water the last days. Diet Coke or Coca-Cola Light is sweetened with a blend containing cyclamates, aspartame, and acesulfame potassium, all free of calories. The etiology of the metabolic acidosis appeared to be a catabolic situation exaggerated by fasting with no intake of calories. The elevated anion gap was due to a severe starvation ketoacidosis, mimicking a diabetic ketoacidosis. Pediatricians should recommend carbohydrate/calorie-containing fluids for rehydration of children with acute fever, diarrhea, or illness.
Assuntos
Bebidas Gaseificadas , Água Potável , Cetose/diagnóstico , Inanição/complicações , Edulcorantes , Pré-Escolar , Cetoacidose Diabética/diagnóstico , Diagnóstico Diferencial , Humanos , Cetose/etiologia , Masculino , Estomatite Herpética/complicaçõesRESUMO
No disponible
Assuntos
Humanos , Feminino , Lactente , Staphylococcus aureus/isolamento & purificação , Bacteriemia/microbiologia , Estomatite Herpética/complicações , Infecções Estafilocócicas/complicações , Herpes Simples/complicaçõesRESUMO
OBJECTIVE: Our aim was to quantify prevalence, incidence, and recurrence of oral lesions (OL) among a population in the Southeast. METHODS: A retrospective study based on chart review was conducted among patients (n = 744) who were ≥19 years of age and initiated highly active antiretroviral therapy (HAART) between January 2000 and June 2006 at the University of Alabama at Birmingham (UAB) 1917 Clinic. Patients' laboratory data and oral conditions were recorded for 2 years after enrollment into the study. RESULTS: During 2 years of follow-up, the period prevalence of individuals experienced at least one OL was 35.6% (266/744). Among all of the 374 episodes of OL, 183 were new cases, while 57 were recurrences. The OL person-visit incidence rate was 0.02 per 100 person-visits. Oropharyngeal candidiasis (OPC) was the most frequent manifestation in terms of period prevalence (74.9%) with a person-visit incident rate of 0.01 per 100 person-visits. CONCLUSIONS: Patients undergoing HAART continue to be affected by HIV-related oral conditions, especially OPC. These results clearly indicate that OL during HIV infection are still highly prevalent in spite of the improvements in medical care and the availability of HAART.